Social Determinants and Cancer
Tuesday, November 5, 2013: 8:30 a.m. - 10:00 a.m.
Social determinants play a critically important role in the incidence, morbidity, and mortality of cancer. This session will address SES disparities in cancer treatment and survival, the efficacy of strategies to enhance smoking cessation among low-SES, predominantly racial/ethnic minority smokers, and geographic disparities in cancer morality in the United States. The content of this session will be geared toward public health and behavioral science researchers, community health educators, and individuals working to address cancer-related health disparities.
Session Objectives: Explain the role of adherence to quality indicators in reducing SES disparities in survival among non-small cell lung cancer patients.
Discuss the results of a group-randomized smoking cessation trial designed to test whether public housing residents trained as Tobacco Treatment Advocates (TTAs) can increase utilization of smoking cessation resources and smoking cessation rates among smokers in public housing.
Define the components of an effective cancer needs assessment.
Describe geographic distribution of US mortality from malignant neoplasm of the trachea, bronchus, and lung according to race, ethnicity, and gender
Describe disparities in prostate cancer treatment selection related to sociodemographic factors.
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by: Cancer Forum
Endorsed by: Medical Care, Asian Pacific Islander Caucus for Public Health
Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)